D.E. Shaw & Co’s Medline Inc MDLN Stock Holding History

D.E. Shaw & Co’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-884,500	Closed	-$37.1M	–	5223
2025 Q4	$37.1M	Buy	+884,500	New	+$37.4M	0.02%	870

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

D.E. Shaw & Co's MDLN Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 884,500 shares — an estimated $37.1M sold.

D.E. Shaw & Co first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $37.1M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

D.E. Shaw & Co reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
D.E. Shaw & Co sold 884,500 Medline Inc shares in Q1 2026, an estimated $37.1M.
D.E. Shaw & Co first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
D.E. Shaw & Co's Medline Inc position peaked at $37.1M in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.